List view / Grid view
After clinical trials showed an increased risk of cancer in…
After clinical trials showed an increased risk of cancer in patients taking Belviq, the FDA has recommended the withdrawal of the drug from the US market.
A new centre has been established by the FDA that…
A new centre has been established by the FDA that will allow the agency to improve the quality and safety of compounded drugs by providing educational programmes to outsourcing facilities.
The FDA has issued a statement on the results from…
The FDA has issued a statement on the results from ranitidine medication testing for nitrosamines, saying that they contain no more NDMA than smoked meats.
The FDA has compiled a report which identifies the root…
The FDA has compiled a report which identifies the root causes of medicine shortages and suggests potential ways to alleviate scarcities.
The FDA has announced its support of a drug manufacturer…
The FDA has announced its support of a drug manufacturer rating system that would allow purchasers to identify which have the most reliable supply, in an effort to reduce shortages.
The examination of ARB drugs by the FDA will be…
The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities.
The FDA has announced that it has granted approval to…
The FDA has announced that it has granted approval to the first nine generic drug applications for Pfizer’s Lyrica treatment.
Three API re-packers who failed to meet current good manufacturing…
Three API re-packers who failed to meet current good manufacturing practice requirements have received warning letters from the FDA.
The Food and Drug Administration has released a list of…
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
